Workflow
Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference Transcript

Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference November 12, 2025 11:00 AM ET Speaker2Ready to go?Yep.Excellent.Speaker1Okay, good morning, everybody, and thanks again for joining us. This is Guggenheim's Healthcare Innovations Conference. I'm really, I'm Seamus Fernandez, one of the senior biopharma analysts here at Guggenheim. You know, really pleased to have with us Aclaris Therapeutics, and immediately to my right is Dr. Neal Walker, CEO and Chair of Aclaris. Also, joining us in the audience is Kevin ...